MTOR and neoplasm: Functional assays showed that CD11b+ Ly6Chigh monocytic cells of tumor-bearing Lyzs-mTOR KO mice had significantly less immunosuppressive than those cells of WT recipients (P < 0.01, Fig. 3G, Suppl.